Report Detail

Other Global (United States, European Union and China) Biologic Injectors Market Research Report 2019-2025

  • RnM3664455
  • |
  • 13 August, 2019
  • |
  • Global
  • |
  • 116 Pages
  • |
  • QYResearch
  • |
  • Other

Biologic injectors are the injecting devices used to deliver drugs and other substances for biological purposes. Biological products such as drugs, growth hormones, antibodies and other complex biological molecules are administered into the body of an organism through biologic injectors. Biologic injectors are basically used for the treatment of various diseases.
Biologic injectors offer different methods of administration such as simple piston, gas, jet and others. They can also be used for the storage or handling of biological molecules. Accurate dosing is one the most important advantages offered by biologic injectors. Thus, the risk of overdose of a drug is significantly reduced with the use of biologic injectors, which is considered as a major advantage of biologics injectors. Biologic injectors can be used for the delivery of general drug or any drug of a specific product line. They can be used for the administration of single doses or multiple doses and the dosage of the drug can be adjusted by the user.
The increasing demand for drug delivery is expected to be the major factor driving the growth of the biologic injectors market over the forecast period. The introduction of disposable and reusable biologic injectors is expected to drive the growth of the biologic injectors market.
North America is expected to be the dominant region in the global biologic injectors market, owing to advancements in healthcare technologies in the region. Europe is expected to hold the second large share in the global biologic injectors market throughout the forecast period.
In 2019, the market size of Biologic Injectors is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Biologic Injectors.

This report studies the global market size of Biologic Injectors, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Biologic Injectors production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
BD
Johnson & Johnson
Roche
Schott
Bayer
Nipro
Ompi
Novartis

Market Segment by Product Type
Disposable Biologic Injectors
Reusable Biologic Injectors

Market Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Biologic Injectors status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Biologic Injectors manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Biologic Injectors are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Biologic Injectors Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Disposable Biologic Injectors
      • 1.3.3 Reusable Biologic Injectors
    • 1.4 Market Segment by Application
      • 1.4.1 Global Biologic Injectors Market Share by Application (2019-2025)
      • 1.4.2 Hospitals
      • 1.4.3 Clinics
      • 1.4.4 Ambulatory Surgical Centers
      • 1.4.5 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Biologic Injectors Production Value 2014-2025
      • 2.1.2 Global Biologic Injectors Production 2014-2025
      • 2.1.3 Global Biologic Injectors Capacity 2014-2025
      • 2.1.4 Global Biologic Injectors Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Biologic Injectors Market Size CAGR of Key Regions
      • 2.2.2 Global Biologic Injectors Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Biologic Injectors Capacity by Manufacturers
      • 3.1.2 Global Biologic Injectors Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Biologic Injectors Revenue by Manufacturers (2014-2019)
      • 3.2.2 Biologic Injectors Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Biologic Injectors Market Concentration Ratio (CR5 and HHI)
    • 3.3 Biologic Injectors Price by Manufacturers
    • 3.4 Key Manufacturers Biologic Injectors Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Biologic Injectors Market
    • 3.6 Key Manufacturers Biologic Injectors Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Disposable Biologic Injectors Production and Production Value (2014-2019)
      • 4.1.2 Reusable Biologic Injectors Production and Production Value (2014-2019)
    • 4.2 Global Biologic Injectors Production Market Share by Type
    • 4.3 Global Biologic Injectors Production Value Market Share by Type
    • 4.4 Biologic Injectors Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Biologic Injectors Consumption by Application

    6 Production by Regions

    • 6.1 Global Biologic Injectors Production (History Data) by Regions 2014-2019
    • 6.2 Global Biologic Injectors Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Biologic Injectors Production Growth Rate 2014-2019
      • 6.3.2 United States Biologic Injectors Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Biologic Injectors Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Biologic Injectors Production Growth Rate 2014-2019
      • 6.4.2 European Union Biologic Injectors Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Biologic Injectors Import & Export
    • 6.5 China
      • 6.5.1 China Biologic Injectors Production Growth Rate 2014-2019
      • 6.5.2 China Biologic Injectors Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Biologic Injectors Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Biologic Injectors Consumption by Regions

    • 7.1 Global Biologic Injectors Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Biologic Injectors Consumption by Type
      • 7.2.2 United States Biologic Injectors Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Biologic Injectors Consumption by Type
      • 7.3.2 European Union Biologic Injectors Consumption by Application
    • 7.4 China
      • 7.4.1 China Biologic Injectors Consumption by Type
      • 7.4.2 China Biologic Injectors Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Biologic Injectors Consumption by Type
      • 7.5.2 Rest of World Biologic Injectors Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 BD
      • 8.1.1 BD Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Biologic Injectors
      • 8.1.4 Biologic Injectors Product Introduction
      • 8.1.5 BD Recent Development
    • 8.2 Johnson & Johnson
      • 8.2.1 Johnson & Johnson Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Biologic Injectors
      • 8.2.4 Biologic Injectors Product Introduction
      • 8.2.5 Johnson & Johnson Recent Development
    • 8.3 Roche
      • 8.3.1 Roche Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Biologic Injectors
      • 8.3.4 Biologic Injectors Product Introduction
      • 8.3.5 Roche Recent Development
    • 8.4 Schott
      • 8.4.1 Schott Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Biologic Injectors
      • 8.4.4 Biologic Injectors Product Introduction
      • 8.4.5 Schott Recent Development
    • 8.5 Bayer
      • 8.5.1 Bayer Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Biologic Injectors
      • 8.5.4 Biologic Injectors Product Introduction
      • 8.5.5 Bayer Recent Development
    • 8.6 Nipro
      • 8.6.1 Nipro Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Biologic Injectors
      • 8.6.4 Biologic Injectors Product Introduction
      • 8.6.5 Nipro Recent Development
    • 8.7 Ompi
      • 8.7.1 Ompi Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Biologic Injectors
      • 8.7.4 Biologic Injectors Product Introduction
      • 8.7.5 Ompi Recent Development
    • 8.8 Novartis
      • 8.8.1 Novartis Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Biologic Injectors
      • 8.8.4 Biologic Injectors Product Introduction
      • 8.8.5 Novartis Recent Development

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Biologic Injectors Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Biologic Injectors Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Biologic Injectors Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Biologic Injectors Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Biologic Injectors Production Forecast by Type
      • 9.7.2 Global Biologic Injectors Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Biologic Injectors Sales Channels
      • 10.2.2 Biologic Injectors Distributors
    • 10.3 Biologic Injectors Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Summary:
      Get latest Market Research Reports on Biologic Injectors. Industry analysis & Market Report on Biologic Injectors is a syndicated market report, published as Global (United States, European Union and China) Biologic Injectors Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Biologic Injectors market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,528.88
      3,793.32
      5,057.76
      3,037.28
      4,555.92
      6,074.56
      502,627.20
      753,940.80
      1,005,254.40
      276,602.40
      414,903.60
      553,204.80
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report